Category: Disease Discoveries
-
‘Cluster Bomb’ Toxin from Cholera Shuts Down Inflammatory Response While Attacking Cells
Northwestern scientists have determined that a toxin secreted by Vibrio cholerae bacteria, the pathogen responsible for cholera, suppresses the body’s normal immune response.
-
Blood Pressure, Mobility and Cognition in Midlife
The cumulative effects of high blood pressure during young adulthood can affect gait and cognitive function during midlife, according to a recent study.
-
New Migration of Brain Tumor Discovered
A previously unknown migration of glioblastoma may explain why current treatments stall out over time, according to a new study.
-
Genetics Offers New Therapeutic Opportunities for Parkinson’s Disease
Northwestern Medicine scientists have recently discovered that two common genetic risk factors for Parkinson’s disease can be regulated with LRRK2 kinase inhibition or GCase enzyme activation, revealing potential for the development of new therapeutics.
-
‘Soft’ Symptoms Detected Before Parkinson’s Disease
People who carry genetic mutations associated with an increased risk for Parkinson’s disease may exhibit minor symptoms long before the disease progresses to affect daily life, according to a study of over 300 patients.
-
Site of Flow Resistance in Glaucoma Identified
According to a recent study, elevated ocular pressure in glaucoma is generated in the wall of a small vessel in the eye, the Schlemm’s canal.
-
AI Model Improves Breast Cancer Detection
An AI model predicted breast cancer in mammograms more accurately than radiologists, reducing false positives and false negatives, according to a new study.
-
Nanoparticle Drug Delivery Could Boost Cancer Therapy
A new lipid nanoparticle drug helped make tumor cells more vulnerable to therapy, significantly prolonging survival in models of glioblastoma.
-
How Gene Mutation Causes Autism and Intellectual Disability
Scientists have discovered why a specific genetic mutation causes intellectual disability and autism spectrum disorder in children.
-
Revived Drug May Serve as New Parkinson’s Treatment
A cancer drug that washed out of clinical trials more than 15 years ago may be the key to slowing the progression of Parkinson’s disease, according to a Northwestern Medicine study.
